InvestorInvesting in the future of life sciences and technology.

ALIVE Israel HealthTech Fund is a mid-to-late stage venture capital fund based in Savyon, Israel, focusing on HealthTech investments. It targets startups in Series A and B, aiming to enhance healthcare delivery through scalable technologies.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
ALIVE Israel HealthTech Fund is a mid-to-late stage investment fund established to optimize value creation across all stages of the investment journey, from clinical trials and FDA approvals to market validation and product adoption. Based in Savyon, Israel, ALIVE supports and accelerates the growth of promising HealthTech technologies through a strategic ecosystem of partners, including leading hospital chains, HMOs, and financial institutions. The fund focuses on innovative platform technologies in sectors such as medical devices, diagnostics, digital health, healthcare IT, and AI/ML, seeking companies with strong management and broad intellectual property protection.
ALIVE invests in mid-to-late stage companies that are developing innovative platform technologies across various sectors, including medical devices, diagnostics, digital health, healthcare IT, and artificial intelligence. The fund seeks companies with strong management teams, robust intellectual property, and a proven execution track record, positioned to leverage the strategic synergies offered by the ALIVE ecosystem.
ALIVE provides significant value to its portfolio companies through access to a robust clinical network, regulatory expertise, and commercial introductions via partnerships with HMOs and hospitals. The fund's strategic ecosystem enhances the growth potential of its investments, facilitating faster market adoption and scaling.
ALIVE focuses on mid-to-late stage companies in the HealthTech sector, specifically those developing innovative platform technologies in medical devices, diagnostics, digital health, healthcare IT, and AI. The fund seeks companies with strong management teams, robust intellectual property, and a proven execution track record.
Founders can pitch to ALIVE by visiting their website at www.alivevc.com and using the contact email provided. A well-prepared pitch deck should include details about the company's technology, market potential, and team.
ALIVE distinguishes itself through its strategic partnerships with leading hospital chains and HMOs, providing portfolio companies with access to a robust clinical network and regulatory expertise. This enhances the growth potential and market adoption of their investments.
ALIVE has a global investment focus, with particular interest in the Asian market. The firm aims to support HealthTech companies that are ready to scale and commercialize their solutions internationally.
ALIVE invests in Series A, Series B, Series C, and growth equity stages, with check sizes that align with the needs of mid-to-late stage companies. Specific amounts may vary based on the company's stage and requirements.
ALIVE offers significant value to its portfolio companies through access to a clinical network, regulatory expertise, and commercial introductions via partnerships with HMOs and hospitals. This support facilitates faster market adoption and scaling of their technologies.
Superscout Pro
Is this page right?Reviewed · How the research works